Seizing the Opportunity: Canada's Chance to Excel in the Life Sciences Sector

As the US life sciences sector becomes increasingly hostile due to trade policy changes and leadership turmoil, Canada has a unique opportunity to capitalize on this trend. With a strong foundation in innovation, research intensity, and early-stage entrepreneurial activity, Canada can establish itself as a global hub for life sciences innovation and manufacturing. However, this requires committing more resources to creating intellectual property, developing advanced-manufacturing capabilities, and incentivizing industry to invest in R&D.

Key Takeaways:

  • The US life sciences sector is roughly US$2.9-trillion, about 10% of its GDP, while Canada's life sciences sector contributes only about $82-billion to the Canadian economy, roughly 2.6% of GDP.
  • Canada scores high in three areas that signal significant potential: innovation capacity, research intensity, and early-stage entrepreneurial activity.
  • Canadian research scientists are recognized globally for their ability to do more with less, and with more resources, they could achieve greater successes.
  • Building a more robust innovation pipeline in Canada requires committing more resources to creating intellectual property, developing advanced-manufacturing capabilities, and incentivizing industry to invest in R&D.
  • The US Department of Defense invests more than $1-billion annually in basic medical research and an additional $4-billion yearly in the life sciences sector.

Statistics:

  • The budget of the US National Institutes of Health (NIH) is approximately US$48-billion.
  • The Canadian Institutes of Health Research (CIHR) has a budget of roughly $1-billion.
  • Canada invests nearly five times less in research and development (R&D) compared to the US per capita.
  • The US life sciences sector contributes roughly 10% of its GDP, while Canada's life sciences sector contributes roughly 2.6% of GDP.
  • The US Department of Defense invests over $5-billion each year in life sciences research and development.

Sources:

  • CSIS (Centre for Strategic and International Studies)
  • The Globe and Mail